Marico Acquires 60% Wellness Brand Cosmix for ₹375 Crore

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Marico Acquires 60% Wellness Brand Cosmix for ₹375 Crore
Overview

Marico Limited is acquiring a 60% stake in Cosmix Wellness, the parent of digital-first functional wellness brand "Cosmix", for ₹225.67 crore, valuing the company at approximately ₹375 crore. This strategic move targets Marico's expansion into premium food and nutrition, leveraging Cosmix's rapid revenue growth and high teen EBITDA margins in vegan and plant-based wellness products. The deal includes an option for Marico to acquire the remaining stake post-FY29.

📉 The Financial Deep Dive

Marico Limited has strategically acquired a 60% stake in Cosmix Wellness Private Limited, the entity behind the prominent digital-first functional wellness brand "Cosmix". This cash transaction, amounting to ₹225.67 crore, pegs Cosmix Wellness's equity valuation at approximately ₹375 crore.

The acquisition aligns with Marico's objective to fortify its presence in premium food and nutrition segments by integrating a digitally native brand with a compelling consumer offering. Cosmix Wellness, established in January 2022, has showcased impressive financial traction. Its turnover surged from ₹5.39 crore in FY2022-23 to ₹24.32 crore in FY2023-24, and further to ₹50.93 crore in FY2024-25.

Notably, the brand has achieved a last 6 months Annual Recurring Revenue (ARR) of approximately ₹100 crore as of January 2026, indicating substantial recent growth acceleration from its FY25 revenue. Cosmix operates with a sustainable high teen EBITDA margin profile, specializing in vegan, gut-friendly, plant-based protein powders, functional superfood blends, and plant-protein food items. Its primary sales channels include its D2C website and leading online plant protein categories.

🚩 Risks & Outlook

  • Specific Risks:
  • Integration risks: Successfully blending Cosmix's digital-first model with Marico's established operations.
  • Execution risk: Achieving projected growth and expansion into new categories and distribution channels.
  • Competition: The functional wellness and nutraceutical market is increasingly competitive.
  • Milestone achievement: Contingent acquisition of the remaining stake depends on Cosmix meeting future performance targets.
  • The Forward View:
  • Investors should watch Marico's integration progress and Cosmix's performance in the next 1-2 quarters, particularly its ARR growth and margin sustainability.
  • The success of this acquisition will be a key indicator of Marico's ability to tap into the premium wellness segment and leverage digital brands.
  • Marico's ability to leverage its distribution network to scale Cosmix's offline presence, if planned, will be a crucial factor.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.